Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GDRX
GDRX logo

GDRX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.040
Open
2.030
VWAP
1.97
Vol
1.57M
Mkt Cap
664.59M
Low
1.940
Amount
3.09M
EV/EBITDA(TTM)
4.64
Total Shares
342.57M
EV
891.04M
EV/OCF(TTM)
5.31
P/S(TTM)
0.87
GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.
Show More

Events Timeline

(ET)
2026-03-27
16:50:00
GoodRx Holdings Chief Accounting Officer Resigns
select
2026-03-06 (ET)
2026-03-06
09:10:00
GoodRx Launches Employer-Sponsored Access to Zepbound KwikPen
select

News

seekingalpha
7.5
03-11seekingalpha
GoodRx Partners with Viatris to Offer Up to 85% Discounts on Medications
  • Discount Program Launch: GoodRx has partnered with Viatris to introduce a new program offering up to 85% discounts on 17 brand-name medications, including the cholesterol drug Lipitor, which is expected to significantly reduce patient medication costs.
  • Extensive Coverage: The discount program will be available at over 70,000 pharmacies across the U.S., making it easier for patients to access necessary medications, thereby enhancing GoodRx's market position in drug price transparency and accessibility.
  • Insurance Patient Benefits: Some Viatris medications will be available on GoodRx for as low as $0–$4 for patients with commercial insurance, a strategy that not only expands GoodRx's user base but may also improve patient adherence to medication regimens.
  • Market Response: GoodRx noted that the selected medications already generate significant search volume on its platform, indicating strong market demand for these drugs, which further solidifies GoodRx's influence in the healthcare sector.
moomoo
7.5
03-11moomoo
GOODRX TEAMS UP WITH VIATRIS TO PROVIDE UP TO 85% DISCOUNTS ON WELL-KNOWN BRAND MEDICATIONS
  • Partnership Announcement: GoodRx has partnered with Viatris to provide significant savings on established brand medications.

  • Savings Details: The collaboration offers up to 85% savings for consumers on select medications through GoodRx's platform.

Newsfilter
7.5
03-06Newsfilter
GoodRx Partners with Eli Lilly to Lower Medication Costs
  • Employer Funding Model: GoodRx Employer Direct enables self-insured employers to subsidize the $449 price of Eli Lilly's Zepbound KwikPen, significantly reducing employee out-of-pocket costs and enhancing access to obesity management medications.
  • Real-Time Integration Mechanism: GoodRx integrates manufacturer discounted pricing with employer funding in real time, ensuring that employer contributions are seamlessly applied to medication costs, creating a more transparent payment pathway and enhancing employer sustainability.
  • Simplified Access Process: This model does not alter employers' core health benefit structures, allowing them to flexibly control subsidy amounts while offering a direct-to-consumer telemedicine solution that simplifies the GLP-1 treatment journey.
  • Market Demand Response: As demand for GLP-1 obesity treatment rises, the collaboration between GoodRx and Eli Lilly demonstrates how to meet employer needs through transparent solutions, further expanding access to obesity management medications.
moomoo
7.5
03-06moomoo
GoodRx Holdings Inc. Enables Self-Insured Employers to Offset $449 Lilly Price for Zebound KwikPen Through GoodRx
  • Company Overview: GoodRx Holdings is a company that operates in the healthcare sector, focusing on providing prescription drug pricing information and discounts to consumers.

  • Financial Insights: The company has a market capitalization of approximately $449 million, indicating its valuation in the stock market.

  • Product Offering: GoodRx offers a service that allows users to compare prices for medications, helping them find the best deals available.

  • Recent Developments: The company has been involved in discussions regarding potential subsidies for self-insured employers, which could impact its business model and revenue streams.

moomoo
7.5
03-06moomoo
GoodRx Holdings Inc. Partners with Eli Lilly to Enhance Employer Access to Zepbound KwikPen
  • Partnership Announcement: GoodRx Holdings has partnered with Eli Lilly to enhance employer access to Zepbound, a medication for weight management.

  • Focus on Accessibility: The collaboration aims to improve the availability of Zepbound for employers, potentially increasing patient access to the treatment.

moomoo
7.5
03-06moomoo
GOODRX TO BROADEN EMPLOYER-SPONSORED AVAILABILITY OF ZEPBOUND® KWIKPEN®
  • Employer-Sponsored Access: GoodRx is expanding its employer-sponsored access program to include Zepbound® and KwikPen® products.
  • Focus on Accessibility: The initiative aims to improve accessibility to these medications for employees through their employers.
Wall Street analysts forecast GDRX stock price to rise
10 Analyst Rating
Wall Street analysts forecast GDRX stock price to rise
4 Buy
4 Hold
2 Sell
Hold
Current: 0.000
sliders
Low
2.60
Averages
4.46
High
7.00
Current: 0.000
sliders
Low
2.60
Averages
4.46
High
7.00
Wells Fargo
Overweight
downgrade
$7
AI Analysis
2026-03-04
Reason
Wells Fargo
Price Target
$7
AI Analysis
2026-03-04
downgrade
Overweight
Reason
Wells Fargo lowered the firm's price target on GoodRx to $3.50 from $7 and keeps an Overweight rating on the shares. The firm acknowledges that unexpected take-rate reset reflects structural headwinds for Prescription Tx, but it also supports Pharma Direct's growth formula. Near-term growth and margins are pressured, Wells argues.
Wells Fargo
Overweight
downgrade
$7
2026-03-03
Reason
Wells Fargo
Price Target
$7
2026-03-03
downgrade
Overweight
Reason
Wells Fargo lowered the firm's price target on GoodRx to $3.50 from $7 and keeps an Overweight rating on the shares. The firm says the company's "unexpected" take-rate reset reflects structural headwinds for its prescription business. Competitive pricing has pushed take rates, and Wells' estimates, lower, the analyst tells investors in a research note. The firm believes that while GoodRx's near-term growth and margins will pressured, its Pharma Direct unit has growth potential.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GDRX
Unlock Now

Valuation Metrics

The current forward P/E ratio for GoodRx Holdings Inc (GDRX.O) is 19.12, compared to its 5-year average forward P/E of 67.41. For a more detailed relative valuation and DCF analysis to assess GoodRx Holdings Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
67.41
Current PE
19.12
Overvalued PE
694.81
Undervalued PE
-560.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
18.81
Current EV/EBITDA
4.40
Overvalued EV/EBITDA
36.04
Undervalued EV/EBITDA
1.57

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
5.63
Current PS
1.18
Overvalued PS
11.16
Undervalued PS
0.11

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what short term stocks to buy now
Intellectia · 72 candidates
Region: USRsi Category: moderateBeta: LowRisk, ModerateRisk, HighRisk, NegativeBetaList Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $6.00 - $20.00Monthly Average Dollar Volume: >= 4,000,000
Ticker
Name
Market Cap$
top bottom
IOT logo
IOT
Samsara Inc
20.40B
CAPR logo
CAPR
Capricor Therapeutics Inc
1.52B
UPXI logo
UPXI
Upexi Inc
62.78M
KC logo
KC
Kingsoft Cloud Holdings Ltd
3.62B
WGS logo
WGS
GeneDx Holdings Corp
2.58B
REPL logo
REPL
Replimune Group Inc
666.36M
stocks under $5 for likely day trade today
Intellectia · 70 candidates
Price: $0.50 - $5.00Price Change Pct: $3.00 - $20.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CIG logo
CIG
Energy of Minas Gerais Co
6.52B
TUYA logo
TUYA
Tuya Inc
1.42B
ODV logo
ODV
Osisko Development Corp
1.15B
GERN logo
GERN
Geron Corp
1.13B
SANA logo
SANA
Sana Biotechnology Inc
1.08B
OLPX logo
OLPX
Olaplex Holdings Inc
1.07B
I need bullish tech stocks for a week
Intellectia · 33 candidates
Sector: Financial Technology (Fintech) & Infrastructure, Software & IT Services, Technology, Technology Equipment, Telecommunications ServicesIndustry: Communications & Networking, Electronic Equipment & Parts, Electric Utilities & IPPs, Integrated Hardware & Software, Semiconductors & Semiconductor Equipment, Software & IT ServicesRegion: USList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $2.00 - $20.00One Week Rise Prob: 60 - 100One Week Predict Return: 0.0% - 100.0%
Ticker
Name
Market Cap$
top bottom
AEHR logo
AEHR
Aehr Test Systems
1.03B
UCTT logo
UCTT
Ultra Clean Holdings Inc
2.68B
CREX logo
CREX
Creative Realities Inc
36.82M
JBL logo
JBL
Jabil Inc
28.63B
LITE logo
LITE
Lumentum Holdings Inc
47.68B
PDD logo
PDD
PDD Holdings Inc
148.98B
best penny stocks to buy short term
Intellectia · 30 candidates
Market Cap: <= 1000.00MRegion: USPrice: $0.50 - $5.00List Exchange: XNYS, XNAS, XASEWeek Price Change Pct: $5.00 - $50.00One Week Rise Prob: >= 60Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
NIU logo
NIU
NIU Technologies
265.08M
GTEC logo
GTEC
Greenland Technologies Holding Corp
18.96M
AMC logo
AMC
AMC Entertainment Holdings Inc
759.16M
ENLV logo
ENLV
Enlivex Therapeutics Ltd
275.36M
ESLA logo
ESLA
Estrella Immunopharma Inc
60.95M
PLX logo
PLX
Protalix Biotherapeutics Inc
232.42M
best penny stocks to buy
Intellectia · 45 candidates
Market Cap: 50.00M - 1000.00MRegion: USPrice: $0.20 - $5.00Eps Ttm: >= 0Beta: ModerateRisk, HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
HIVE logo
HIVE
HIVE Digital Technologies Ltd
695.26M
REI logo
REI
Ring Energy Inc
246.60M
GAU logo
GAU
Galiano Gold Inc
691.04M
LDI logo
LDI
loanDepot Inc
726.45M
ITRG logo
ITRG
Integra Resources Corp
671.92M
MVST logo
MVST
Microvast Holdings Inc
859.84M
penny stock to buy for data center AI
Intellectia · 3 candidates
Market Cap: <= 2.00BPrice: <= $5.00Themes: AI Beneficiary, US Well-Known Retailers, Education & Training Services, Pharmaceutical Retailers, Airlines, Movie and Entertainment, BlockchainWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
GDRX logo
GDRX
GoodRx Holdings Inc
875.74M
HIVE logo
HIVE
HIVE Digital Technologies Ltd
768.63M
CHGG logo
CHGG
Chegg Inc
83.36M
stocks under $5 today worth buying
Intellectia · 41 candidates
Market Cap: >= 300.00MPrice: <= $5.00Beta: ModerateRiskWeekly Average Turnover: >= 1,000,000Rsi 14: 30 - 70
Ticker
Name
Market Cap$
top bottom
WIT logo
WIT
Wipro Ltd
27.24B
LPL logo
LPL
LG Display Co Ltd
4.32B
CSAN logo
CSAN
Cosan SA
4.02B
COTY logo
COTY
Coty Inc
2.85B
RLX logo
RLX
RLX Technology Inc
2.75B
BTE logo
BTE
Baytex Energy Corp
2.64B

Whales Holding GDRX

S
Silver Lake Technology Management, L.L.C.
Holding
GDRX
+3.18%
3M Return
T
TCMI Inc.
Holding
GDRX
-25.98%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is GoodRx Holdings Inc (GDRX) stock price today?

The current price of GDRX is 1.94 USD — it has decreased -4.9

What is GoodRx Holdings Inc (GDRX)'s business?

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.

What is the price predicton of GDRX Stock?

Wall Street analysts forecast GDRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GDRX is4.46 USD with a low forecast of 2.60 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is GoodRx Holdings Inc (GDRX)'s revenue for the last quarter?

GoodRx Holdings Inc revenue for the last quarter amounts to 194.78M USD, decreased -1.91

What is GoodRx Holdings Inc (GDRX)'s earnings per share (EPS) for the last quarter?

GoodRx Holdings Inc. EPS for the last quarter amounts to 0.02 USD, decreased 0.00

How many employees does GoodRx Holdings Inc (GDRX). have?

GoodRx Holdings Inc (GDRX) has 697 emplpoyees as of March 29 2026.

What is GoodRx Holdings Inc (GDRX) market cap?

Today GDRX has the market capitalization of 664.59M USD.